NCT06945406View on ClinicalTrials.gov

A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes

PHASE1RecruitingINTERVENTIONAL

Enrollment

132

Participants

Timeline

Start Date

May 16, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions

HealthyDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Interventions

DRUG

LY4057996 SC

Administered SC

DRUG

LY4057996 IV

Administered IV

DRUG

Placebo SC

Administered SC

DRUG

Placebo IV

Administered IV

DRUG

Degludec SC

Administered SC

DRUG

Lispro SC

Administered SC

DRUG

Degludec IV

Administered IV

DRUG

Pre-study basal insulin SC

Administered SC

Trial Locations (1)

41460

RECRUITING

Profil Institut für Stoffwechselforschung, Neuss

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY